A detailed history of Braidwell LP transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Braidwell LP holds 3,499,427 shares of RLAY stock, worth $15.2 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
3,499,427
Previous 3,006,799 16.38%
Holding current value
$15.2 Million
Previous $19.6 Billion 26.38%
% of portfolio
0.7%
Previous 0.61%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.23 - $9.51 $3.07 Million - $4.68 Million
492,628 Added 16.38%
3,499,427 $24.8 Billion
Q2 2024

Aug 14, 2024

SELL
$5.9 - $8.02 $4.35 Million - $5.91 Million
-737,200 Reduced 19.69%
3,006,799 $19.6 Billion
Q1 2024

May 15, 2024

BUY
$7.5 - $12.07 $28.1 Million - $45.2 Million
3,743,999 New
3,743,999 $31.1 Billion

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $522M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Braidwell LP Portfolio

Follow Braidwell LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.